Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome: An Intertwined Epidemic
Journal of Pathology and Diagnostic Microbiology · 2024 · 1
DOI: 10.59462/jpdm.1.1.103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pathology and Diagnostic Microbiology, 2024.
Abstract (Originalsprache)
Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome (MetS) are two interconnected health conditions that have become increasingly prevalent worldwide. NAFLD is characterized by excessive fat accumulation in the liver, while MetS is a cluster of conditions including obesity, insulin resistance, hypertension, and dyslipidemia. The two conditions share common pathophysiological mechanisms and risk factors, and individuals with NAFLD are more likely to develop MetS and vice versa. The growing burden of NAFLD and MetS poses significant challenges to global health, highlighting the need for a comprehensive understanding of their relationship and effective management strategies.
Zitieren
APA
(2024). Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome: An Intertwined Epidemic. Journal of Pathology and Diagnostic Microbiology, 1. https://doi.org/10.59462/jpdm.1.1.103
Vancouver
Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome: An Intertwined Epidemic. Journal of Pathology and Diagnostic Microbiology. 2024;1. doi:10.59462/jpdm.1.1.103
BibTeX
@article{euvimed2024,
title = {Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome: An Intertwined Epidemic},
journal = {Journal of Pathology and Diagnostic Microbiology},
year = {2024},
volume = {1},
doi = {10.59462/jpdm.1.1.103}
}
EUVIMED